Showing results (131-140 of 153) with videos related to
Sort By:
Pageof 16
Plos Pathogens|March 22, 2022
Biomechanical interactions of Schistosoma mansoni eggs with vascular endothelial cells facilitate egg extravasationYi-Ting Yeh, Danielle E Skinner, Ernesto Criado-Hidalgo, et al.Lancet (London, England)|January 19, 2016
Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trialSagar Lonial, Brendan M Weiss, Saad Z Usmani, et al.Blood|January 31, 2016
Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failurePaul G Richardson, Marcie L Riches, Nancy A Kernan, et al.Cancers|March 6, 2021
Analysis of Post-Transplant Lymphoproliferative Disorder (PTLD) Outcomes with Epstein-Barr Virus (EBV) Assessments-A Single Tertiary Referral Center Experience and Review of LiteratureEric Lau, Justin Tyler Moyers, Billy Chen Wang, et al.Biorxiv : the Preprint Server for Biology|April 17, 2023
Development of subunit selective substrates for Trichomonas vaginalis proteasomePavla Fajtova, Brianna M Hurysz, Yukiko Miyamoto, et al.Frontiers in Immunology|September 20, 2021
Immune Recovery Following Autologous Hematopoietic Stem Cell Transplantation in HIV-Related Lymphoma Patients on the BMT CTN 0803/AMC 071 TrialPolina Shindiapina, Maciej Pietrzak, Michal Seweryn, et al.The Lancet. Haematology|March 16, 2025
Safety and activity of talquetamab in patients with relapsed or refractory multiple myeloma (MonumenTAL-1): a multicentre, open-label, phase 1-2 studyAjai Chari, Cyrille Touzeau, Carolina Schinke, et al.World Journal of Gastroenterology|June 3, 2015
Utility of the low-accelerating-dose regimen in 182 liver recipients with recurrent hepatitis C virusKieron B L Lim, Hamid R Sima, M Isabel Fiel, et al.Leukemia|August 12, 2020
International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trialsLuciano J Costa, Benjamin A Derman, Susan Bal, et al.The Lancet. Haematology|February 3, 2022
Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working GroupNoopur S Raje, Elias Anaissie, Shaji K Kumar, et al.Pageof 16